Citations for
1FGF19, FGFR4
Dissecting the Role of the FGF19-FGFR4 Signaling Pathway in Cancer Development and Progression.
Liu Y, Cao M, Cai Y, Li X, Zhao C, Cui R.
Front Cell Dev Biol 8:95. doi: 10.3389/fcell.2020.00095. eCollection 2020. Review. 2020
2FGFR4
FGFR4 provides the conduit to facilitate FGF19 signaling in breast cancer progression.
Zhao X, Xu F, Dominguez NP, Xiong Y, Xiong Z, Peng H, Shay C, Teng Y.
Mol Carcinog 57(11):1616-1625. doi: 10.1002/mc.22884. Epub 2018 Aug 22. 2018
3FGFR4, FOXC1, ITGA7
Forkhead box C1 promotes colorectal cancer metastasis through transactivating ITGA7 and FGFR4 expression.
Liu J, Zhang Z, Li X, Chen J, Wang G, Tian Z, Qian M, Chen Z, Guo H, Tang G, Huang W, Tian D, Wang D, Nie Y, Fan D, Wu K, Xia L.
Oncogene 37(41):5477-5491. doi: 10.1038/s41388-018-0355-4. Epub 2018 Jun 8. 2018
4FGFR3, FGFR4
FGF receptors control alveolar elastogenesis.
Li R, Herriges JC, Chen L, Mecham RP, Sun X.
Development 144(24):4563-4572. doi: 10.1242/dev.149443. Epub 2017 Nov 9. 2017
5FGF23, FGFR4
FGF23/FGFR4-mediated left ventricular hypertrophy is reversible.
Grabner A, Schramm K, Silswal N, Hendrix M, Yanucil C, Czaya B, Singh S, Wolf M, Hermann S, Stypmann J, Di Marco GS, Brand M, Wacker MJ, Faul C.
Sci Rep 7(1):1993. doi: 10.1038/s41598-017-02068-6. 2017
6FGF19, FGFR4
Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival.
Tiong KH, Tan BS, Choo HL, Chung FF, Hii LW, Tan SH, Khor NT, Wong SF, See SJ, Tan YF, Rosli R, Cheong SK, Leong CO.
Oncotarget 7(36):57633-57650. doi: 10.18632/oncotarget.9328. 2016
7FGF23, FGFR4
Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy.
Grabner A, Amaral AP, Schramm K, Singh S, Sloan A, Yanucil C, Li J, Shehadeh LA, Hare JM, David V, Martin A, Fornoni A, Di Marco GS, Kentrup D, Reuter S, Mayer AB, Pavenstädt H, Stypmann J, Kuhn C, Hille S, Frey N, Leifheit-Nestler M, Richter B, Haffner D, Abraham R, Bange J, Sperl B, Ullrich A, Brand M, Wolf M, Faul C.
Cell Metab 22(6):1020-32. doi: 10.1016/j.cmet.2015.09.002. Epub 2015 Oct 1. 2015
8FGFR4
Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma.
Sheu MJ, Hsieh MJ, Chiang WL, Yang SF, Lee HL, Lee LM, Yeh CB.
PLoS One 10(4):e0122961. doi: 10.1371/journal.pone.0122961. eCollection 2015. 2015
9FGFR4
Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma.
Xu YF, Yang XQ, Lu XF, Guo S, Liu Y, Iqbal M, Ning SL, Yang H, Suo N, Chen YX.
Biochem Biophys Res Commun 446(1):54-60. doi: 10.1016/j.bbrc.2014.02.050. Epub 2014 Feb 22. 2014
10FGFR4
Fibroblast growth factor receptor 4 as a potential prognostic and therapeutic marker in colorectal cancer.
Li CS, Zhang SX, Liu HJ, Shi YL, Li LP, Guo XB, Zhang ZH.
Biomarkers 19(1):81-5. doi: 10.3109/1354750X.2013.876555. Epub 2014 Jan 13. 2014
11DUP5QD, FGFR4
Bilateral radial agenesis with absent thumbs, complex heart defect, short stature, and facial dysmorphism in a patient with pure distal microduplication of 5q35.2-5q35.3.
Jamsheer A, Sowińska A, Simon D, Jamsheer-Bratkowska M, Trzeciak T, Latos-Bieleńska A.
BMC Med Genet 14:13. doi: 10.1186/1471-2350-14-13. 2013
12FGFR4
FGFR4 promotes stroma-induced epithelial-to-mesenchymal transition in colorectal cancer.
Liu R, Li J, Xie K, Zhang T, Lei Y, Chen Y, Zhang L, Huang K, Wang K, Wu H, Wu M, Nice EC, Huang C, Wei Y.
Cancer Res 73(19):5926-35. doi: 10.1158/0008-5472.CAN-12-4718. Epub 2013 Aug 13. 2013
13FGFR4
Association between fibroblast growth factor receptor 4 polymorphisms and risk of hepatocellular carcinoma.
Yang Y, Zhou Y, Lu M, An Y, Li R, Chen Y, Lu DR, Jin L, Zhou WP, Qian J, Wang HY.
Mol Carcinog 51(7):515-21. doi: 10.1002/mc.20805. Epub 2011 Jun 7. 2012
14FGF19, FGFR4
Soluble FGFR4 extracellular domain inhibits FGF19-induced activation of FGFR4 signaling and prevents nonalcoholic fatty liver disease.
Chen Q, Jiang Y, An Y, Zhao N, Zhao Y, Yu C.
Biochem Biophys Res Commun 409(4):651-6. Epub 2011 May 17. 2011
15FGF19, FGF21, FGF23, FGFR4
FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation.
Wu X, Ge H, Lemon B, Vonderfecht S, Weiszmann J, Hecht R, Gupte J, Hager T, Wang Z, Lindberg R, Li Y.
J Biol Chem 285(8):5165-70. Epub 2009 Dec 15. 2010
16FGFR4, MMP14
FGF receptor-4 (FGFR4) polymorphism acts as an activity switch of a membrane type 1 matrix metalloproteinase-FGFR4 complex.
Sugiyama N, Varjosalo M, Meller P, Lohi J, Chan KM, Zhou Z, Alitalo K, Taipale J, Keski-Oja J, Lehti K.
Proc Natl Acad Sci U S A 107(36):15786-91. Epub 2010 Aug 23.PMID: 20798051 2010
17FGFR4, KLB
Metabolic regulator betaKlotho interacts with fibroblast growth factor receptor 4 (FGFR4) to induce apoptosis and inhibit tumor cell proliferation.
Luo Y, Yang C, Lu W, Xie R, Jin C, Huang P, Wang F, McKeehan WL.
J Biol Chem 285(39):30069-78. Epub 2010 Jul 23.PMID: 20657013 2010
18FGFR4
FGFR4 transmembrane domain polymorphism and cancer risk: A meta-analysis including 8555 subjects.
Xu W, Li Y, Wang X, Chen B, Wang Y, Liu S, Xu J, Zhao W, Wu J.
Eur J Cancer ur J Cancer. 2010 Jul 16. [Epub ahead of print]PMID: 20638838 2010
19FGFR4, FOXO1
FGF15/FGFR4 integrates growth factor signaling with hepatic bile acid metabolism and insulin action.
Shin DJ, Osborne TF.
J Biol Chem 284(17):11110-20. Epub 2009 Feb 23. 2009
20FGFR4
Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention.
Ho HK, Pok S, Streit S, Ruhe JE, Hart S, Lim KS, Loo HL, Aung MO, Lim SG, Ullrich A.
J Hepatol 50(1):118-27. Epub 2008 Oct 12.PMID: 19008009 2009
21APC, ATM, EPHA3, ERBB2, ERBB4, FGFR4
Somatic mutations affect key pathways in lung adenocarcinoma.
Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, Sougnez C, Greulich H, Muzny DM, Morgan MB, Fulton L, Fulton RS, Zhang Q, Wendl MC, Lawrence MS, Larson DE, Chen K, Dooling DJ, Sabo A, Hawes AC, Shen H, Jhangiani SN, Lewis LR, Hall O, Zhu Y, Mathew T, Ren Y, Yao J, Scherer SE, Clerc K, Metcalf GA, Ng B, Milosavljevic A, Gonzalez-Garay ML, Osborne JR, Meyer R, Shi X, Tang Y, Koboldt DC, Lin L, Abbott R, Miner TL, Pohl C, Fewell G, Haipek C, Schmidt H, Dunford-Shore BH, Kraja A, Crosby SD, Sawyer CS, Vickery T, Sander S, Robinson J, Winckler W, Baldwin J, Chirieac LR, Dutt A, Fennell T, Hanna M, Johnson BE, Onofrio RC, Thomas RK, Tonon G, Weir BA, Zhao X, Ziaugra L, Zody MC, Giordano T, Orringer MB, Roth JA, Spitz MR, Wistuba II, Ozenberger B, Good PJ, Chang AC, Beer DG, Watson MA, Ladanyi M, Broderick S, Yoshizawa A, Travis WD, Pao W, Province MA, Weinstock GM, Varmus HE, Gabriel SB, Lander ES, Gibbs RA, Meyerson M, Wilson RK.
Nature 455(7216):1069-75. 2008
22FGFR4
FGFR4 and its novel splice form in myogenic cells: Interplay of glycosylation and tyrosine phosphorylation.
Kwiatkowski BA, Kirillova I, Richard RE, Israeli D, Yablonka-Reuveni Z.
J Cell Physiol 215(3):803-17.PMID: 18186042 2008
23FGF23, FGFR3, FGFR4
FGFR3 and FGFR4 do not mediate renal effects of FGF23.
Liu S, Vierthaler L, Tang W, Zhou J, Quarles LD.
J Am Soc Nephrol 19(12):2342-50. Epub 2008 Aug 27.PMID: 18753255 2008
24FGFR4, KLB
Liver-specific activities of FGF19 require Klotho beta.
Lin BC, Wang M, Blackmore C, Desnoyers LR.
J Biol Chem 282(37):27277-84. Epub 2007 Jul 11.PMID: 17627937 2007
25FGFR4
Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis.
Matakidou A, El Galta R, Rudd MF, Webb EL, Bridle H, Eisen T, Houlston RS.
Br J Cancer 96(12):1904-7. Epub 2007 May 22. 2007
26FGFR4, MYOD1, TEAD2
Fgfr4 is required for effective muscle regeneration in vivo. Delineation of a MyoD-Tead2-Fgfr4 transcriptional pathway.
Zhao P, Caretti G, Mitchell S, McKeehan WL, Boskey AL, Pachman LM, Sartorelli V, Hoffman EP.
J Biol Chem 281(1):429-38. Epub 2005 Nov 2. 2006
27FGFR4, CYP7A1
Independent repression of bile acid synthesis and activation of c-Jun N-terminal kinase (JNK) by activated hepatocyte fibroblast growth factor receptor 4 (FGFR4) and bile acids.
Yu C, Wang F, Jin C, Huang X, McKeehan WL.
J Biol Chem 280(18):17707-14. Epub 2005 Mar 4. 2005
28FGFR4
FGFR4 signaling is a necessary step in limb muscle differentiation.
Marics I, Padilla F, Guillemot JF, Scaal M, Marcelle C.
Development 129(19):4559-69. 2002
29HNF1A, FGFR4
FGFR4 overexpression in pancreatic cancer is mediated by an intronic enhancer activated by HNF1alpha.
Shah RN, Ibbitt JC, Alitalo K, Hurst HC.
Oncogene 21(54):8251-61. 2002
30FGFR4
Identification of a novel alternative splicing of human FGF receptor 4: soluble-form splice variant expressed in human gastrointestinal epithelial cells.
Takaishi S, Sawada M, Morita Y, Seno H, Fukuzawa H, Chiba T.
Biochem Biophys Res Commun 267(2):658-62. 2000
31FGFR4
Fibroblast growth factor receptor 4 (FGFR4) is expressed in adult rat and human retinal photoreceptors and neurons.
Fuhrmann V, Kinkl N, Leveillard T, Sahel J, Hicks D.
J Mol Neurosci 13(1-2):187-97. 1999
32FGFR4
Genomic structure and complete sequence of the human FGFR4 gene.
Kostrzewa M, Muller U.
Mamm Genome 9(2):131-5. 1998
33FGFR4
Analysis of patients with craniosynostosis syndromes for a pro246Arg mutation of FGFR4.
Gaudenz K, et al.
Mol Genet Metab 64 : 76-79. 1998
34FLT4, FGFR4
Localization of two tyrosine kinase receptor genes with respect to the 5q35 chromosomal breakpoint of Ki-I lymphoma cell lines.
PŽbusque MJ, et al.
Genes Chromosomes Cancer 8 : 119-126. 1993
35FGFR4
Localization of the fibroblast growth factor receptor-4 gene to chromosome region 5q33-qter.
Armstrong E, et al.
Genes Chromosomes Cancer 4 : 94-98. 1992
36FGFR4
RFLPs in the fibroblast growth factor receptor-4 locus (FGFR4) in 5q33-qter.
Armstrong E, et al.
Nucleic Acids Res 19 : 5096. 1991